MRI慢性阻塞性肺疾病生物标志物指导支气管镜肺减容术的潜在作用
回顾性评估22例适合支气管镜肺减容术的重度肺气肿患者,比较CT肺气肿定量与MRI通气缺陷百分比对肺叶病变严重程度的排序。7/22例患者两种方法预测的最严重肺叶不同,两种方法分类一致性为一般至中等(Cohen κ=0.40-0.59)。作者认为MRI可提供互补的通气和肺气肿生物标志物,可能改变BLVR靶叶选择。
要点
- CT与MRI对最严重肺叶的判定在部分患者中不一致,需关注MRI通气缺陷分布。
- CT靶叶邻近肺叶存在大MRI通气缺陷时,可能影响BLVR决策或改变靶叶。
- CT肺气肿定量采用RA950,MRI采用通气缺陷百分比独立排序肺叶病变严重程度。
核心结论
- 在这项概念验证性回顾分析中,定量MRI通气与CT肺气肿测量在超过30%的患者中给出不同的BLVR靶叶;CT靶叶邻近肺叶存在大MRI通气缺陷可能改变进行BLVR的决定或引导至不同靶叶。
研究设计与样本
- 回顾性评估加拿大胸科影像网络队列中22例适合BLVR的COPD患者,采用CT肺气肿定量(RA950)与MRI通气缺陷百分比独立排序肺叶病变严重程度。
诊断标准与关键数值
- CT肺气肿定量采用相对面积<-950 Hounsfield单位(RA950);MRI采用通气缺陷百分比;两种方法独立用于肺叶病变严重程度排序;CT与MRI对最严重及第二严重肺叶分类的组间信度Cohen κ=0.40-0.59。
临床应用与阅片要点
- 作者认为MRI通气与CT肺气肿测量提供不同的BLVR靶叶,MRI通气缺陷可能补充CT用于确定最合适的肺叶靶点。
局限性
- 原文为概念验证性回顾分析。
- 样本量为22例。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: In patients with severe emphysema and poor quality of life, bronchoscopic lung volume reduction (BLVR) may be considered and guided based on lobar emphysema severity. In particular, x-ray computed tomography (CT) emphysema measurements are used to identify the most diseased and the second-most diseased lobes as BLVR targets. Inhaled gas magnetic resonance imaging (MRI) also provides chronic obstructive pulmonary disease (COPD) biomarkers of lobar emphysema and ventilation abnormalities. Our objective was to retrospectively evaluate CT and MRI biomarkers of lobar emphysema and ventilation in patients with COPD eligible for BLVR. We hypothesized that MRI would provide complementary biomarkers of emphysema and ventilation that help determine the most appropriate lung lobar targets for BLVR in patients with COPD.
MATERIALS AND METHODS: We retrospectively evaluated 22 BLVR-eligible patients from the Thoracic Imaging Network of Canada cohort (diffusing capacity of the lung for carbon monoxide = 37 ± 12%predicted, forced expiratory volume in 1 second = 34 ± 7%predicted, total lung capacity = 131 ± 17%predicted, and residual volume = 216 ± 36%predicted). Lobar CT emphysema, measured using a relative area of <-950 Hounsfield units (RA950) and MRI ventilation defect percent, was independently used to rank lung lobe disease severity.
RESULTS: In 7 of 22 patients, there were different CT and MRI predictions of the most diseased lobe. In some patients, there were large ventilation defects in lobes not targeted by CT, indicative of a poorly ventilated lung. CT and MRI classification of the most diseased and the second-most diseased lobes showed a fair-to-moderate intermethod reliability (Cohen κ = 0.40-0.59).
CONCLUSIONS: In this proof-of-concept retrospective analysis, quantitative MRI ventilation and CT emphysema measurements provided different BLVR targets in over 30% of the patients. The presence of large MRI ventilation defects in lobes next to CT-targeted lobes might also change the decision to proceed or to guide BLVR to a different lobar target.
引用
- Adams CJ, Capaldi DPI, Di Cesare R, et al. On the Potential Role of MRI Biomarkers of COPD to Guide Bronchoscopic Lung Volume Reduction. Acad Radiol. 2017. PMID: 29051040. doi:10.1016/j.acra.2017.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。